can tirzepatide cause low iron GLP1s and Deficiency Anemia Is there a causal link

Add phentermine at the lowest effective dose, typically 8 mg three times daily or 15 mg once daily in the morning

While some individuals do use both, the combination requires careful medical supervision to ensure your blood sugar stays in a healthy range

Lab work may be required

Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): A double-blind, randomised, phase 3 trial

Side Effects Reported in Clinical Trials The Phase 2 trials provided initial safety data for retatrutide

Patients start at 2.5 mg weekly for 4 weeks, then escalate by 2.5 mg increments every 4 weeks as tolerated until reaching maintenance dose, typically 10 mg or 15 mg